1-20 of 5,770 results for member:"Lord Avebury"
Librarians' tools
- Search time
- 0.603 seconds
- Solr query time
- 0.014 seconds
- Search query
- member:"Lord Avebury"
- We searched for
- member_ses:298961
Type
House
Session
More
Year
Department
More
Member
More
Primary member
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
To ask Her Majesty’s Government what assessment they have made of the recommendations to the UN Security Council members in the Human Rights Watch report of 26 November, What Military Target Was in My Brother's House: Unlawful Coalition Airstrikes in Yemen.
To ask Her Majesty’s Government what assessment they have made of the recommendations to the UN Security Council members in the Human Rights Watch report of 26 November, What Military Target Was in My Brother's House: Unlawful Coalition Airstrikes in Yemen.
To ask Her Majesty’s Government whether they have investigated claims by Human Rights Watch and Amnesty International that weapons supplied by the UK, such as Paveway IV missiles, have been used by Saudi Arabia to attack civilian targets in Yemen; and whether they have taken legal advice about the UK's...
To ask Her Majesty’s Government whether they have investigated claims by Human Rights Watch and Amnesty International that weapons supplied by the UK, such as Paveway IV missiles, have been used by Saudi Arabia to attack civilian targets in Yemen; and whether they have taken legal advice about the UK's...
To ask Her Majesty’s Government what is their response to the recommendation by Human Rights Watch in its report on the treatment of detainees in Bahrain, The Blood of People Who Don't Cooperate, that the UK should suspend funding, support and training for security service reform until Bahrain enacts listed...
To ask Her Majesty’s Government what is their response to the recommendation by Human Rights Watch in its report on the treatment of detainees in Bahrain, The Blood of People Who Don't Cooperate, that the UK should suspend funding, support and training for security service reform until Bahrain enacts listed...
The British Government consistently and unreservedly condemns torture and cruel, inhuman or degrading treatment or punishment and it is a priority for us to combat it wherever and whenever it occurs. We are aware of ongoing allegations against Ministry of Interior personnel, and we have expressed our concerns to the authorities. The Government of Bahrain has previously committed to consider ratifying the Optional Protocol of the Convention Against Torture. The UK strongly supports this and we have been working with the authorities to share best practice on torture prevention measures. We also continue to ask the Government of Bahrain to allow a visit of the UN Special Rapporteur on Torture.
We welcome the progress made by Bahrain on their reform programme particularly in the areas of youth justice, the establishment and increasing effectiveness of the Ombudsman’s office, the Prisoner and Detainees’ Rights Commission and the reformed National Institute of Human Rights. We continue to work with the Government of Bahrain to ensure momentum and progress on its reforms, for the benefit of all Bahrainis.
The Government of Bahrain has asked the international community for their assistance in implementing the reforms necessary to improve the human rights situation, including in the security services. We strongly support them in their efforts and that is why we will continue to offer bilateral assistance for Bahrain’s reform programmes. In August, following a meeting with His Majesty King Hamad bin Isa Al Khalifa, the Prime Minister, my right hon. Friend the Member for Witney (Mr Cameron), reiterated the UK’s support for ongoing political reform in Bahrain but encouraged His Majesty to continue to demonstrate substantive progress in all areas. Our package of technical assistance is focused on strengthening human rights and the rule of law, in line with the Bahrain Independent Commission of Inquiry and the Universal Periodic Review.
To ask Her Majesty’s Government what assessment they have made of whether it is now possible to establish baseline data that could be used to determine whether the law on caste discrimination is working effectively.
To ask Her Majesty’s Government what assessment they have made of whether it is now possible to establish baseline data that could be used to determine whether the law on caste discrimination is working effectively.
This Government has been giving consideration to the legal position on caste discrimination in light of the Tirkey v Chandhok Employment Appeal Tribunal judgment which suggests there is an existing legal remedy for claims of caste-associated discrimination under the ‘ethnic origins’ element of Section 9 of the Equality Act 2010.
Our consideration of the research report commissioned by the coalition Government, designed to determine the feasibility of conducting a national survey to quantify the extent of caste discrimination in Britain, is part of this process.
We remain mindful of the Open Government Action Plan published by the Coalition Government in 2013, to the extent that this concerns the results of commissioned research.
To ask Her Majesty’s Government what further consideration they have given to whether amending the Equality Act 2010 to include the word "caste" would change or clarify the legal position, given the provisions already in place in section 9(5)(a) of that Act.
To ask Her Majesty’s Government what further consideration they have given to whether amending the Equality Act 2010 to include the word "caste" would change or clarify the legal position, given the provisions already in place in section 9(5)(a) of that Act.
This Government has been giving consideration to the legal position on caste discrimination in light of the Tirkey v Chandhok Employment Appeal Tribunal judgment which suggests there is an existing legal remedy for claims of caste-associated discrimination under the ‘ethnic origins’ element of Section 9 of the Equality Act 2010.
Our consideration of the research report commissioned by the coalition Government, designed to determine the feasibility of conducting a national survey to quantify the extent of caste discrimination in Britain, is part of this process.
We remain mindful of the Open Government Action Plan published by the Coalition Government in 2013, to the extent that this concerns the results of commissioned research.
To ask Her Majesty’s Government what assessment they have made of the compatibility of their decision to delay the publication of their feasibility study regarding establishing baseline data to evaluate the effectiveness of caste legislation with their commitment to open government.
To ask Her Majesty’s Government what assessment they have made of the compatibility of their decision to delay the publication of their feasibility study regarding establishing baseline data to evaluate the effectiveness of caste legislation with their commitment to open government.
This Government has been giving consideration to the legal position on caste discrimination in light of the Tirkey v Chandhok Employment Appeal Tribunal judgment which suggests there is an existing legal remedy for claims of caste-associated discrimination under the ‘ethnic origins’ element of Section 9 of the Equality Act 2010.
Our consideration of the research report commissioned by the coalition Government, designed to determine the feasibility of conducting a national survey to quantify the extent of caste discrimination in Britain, is part of this process.
We remain mindful of the Open Government Action Plan published by the Coalition Government in 2013, to the extent that this concerns the results of commissioned research.
My Lords, I, too, begin by congratulating my friend, the noble Lord, Lord Alton, on his masterly presentation of the case for the Bill, and on the assiduity with which he has pursued compensation for mesothelioma sufferers over a great many years with determination and thoroughness. I know how many...
My Lords, I, too, begin by congratulating my friend, the noble Lord, Lord Alton, on his masterly presentation of the case for the Bill, and on the assiduity with which he has pursued compensation for mesothelioma sufferers over a great many years with determination and thoroughness. I know how many...
To ask Her Majesty’s Government whether they will amend the gov.uk website to reflect the changes made by the Immigration Act 2014 to the British Nationality Act 1981; and whether they will also cause legislation.gov.uk to be updated accordingly.
To ask Her Majesty’s Government whether they will amend the gov.uk website to reflect the changes made by the Immigration Act 2014 to the British Nationality Act 1981; and whether they will also cause legislation.gov.uk to be updated accordingly.
Section 65 of the Immigration Act 2014 was commenced on 6 April 2015 and inserted new registration provisions into the British Nationality Act 1981 for persons born before 1 July 2006 to British fathers. Information about this is published on the Gov.UK website at: https://www.gov.uk/register-british-citizen/born-before-2006-british-father.
The National Archives is bringing all the primary legislation on legislation.gov.uk up to date. The British Nationality Act 1981 (c. 61) is up to date to the end of 2009. A further 50 subsequent amendments affecting this Act have been identified. A fully revised version, including the effects by the Immigration Act 2014 (c. 22), will be published and available by the end of 2015.
To ask Her Majesty’s Government which drugs have been delisted from the Cancer Drugs Fund; how many patients are currently being treated with each drug; and what steps they are taking to develop a new system for prescribing each drug.
To ask Her Majesty’s Government which drugs have been delisted from the Cancer Drugs Fund; how many patients are currently being treated with each drug; and what steps they are taking to develop a new system for prescribing each drug.
Details of the drugs removed from the national Cancer Drugs Fund (CDF) list following re-prioritisation are shown in tables 1 and 2. The latest version of the list is available on NHS England’s website at: www.england.nhs.uk/ourwork/pe/cdf/. A copy is attached.
Table 1: Confirmation of previously notified drugs and indications delisted on 12 March 2015 | |
Drug | Indication removed |
Aflibercept | 2nd line in combination with irinotecan-based combination chemotherapy for metastatic colorectal cancer |
Bendamustine | Treatment of patients with indolent non-Hodgkin’s lymphoma who are refractory to rituximab |
Bevacizumab | 1st line in combination with oxaliplatin–based combination chemotherapy for metastatic colorectal cancer |
Bevacizumab | 1st line in combination with irinotecan–based combination chemotherapy for metastatic colorectal cancer |
Bevacizumab | 1st line in combination with single agent fluoropyrimidine–based chemotherapy for metastatic colorectal cancer. |
Bevacizumab | In combination with carboplatin and gemcitabine chemotherapy for recurrent platinum sensitive ovarian cancer |
Bortezomib | Re-treatment in patients with relapsed myeloma |
Bortezomib | Treatment of patients with relapsed Waldenstrom’s macroglobulinaemia |
Bortezomib | Treatment of patients with relapsed mantle cell lymphoma |
Bosutinib | Treatment of blast phase chronic myeloid leukaemia |
Cetuximab | 2nd line in combination with irinotecan chemotherapy for metastatic colorectal cancer in patients with RAS wild type (non-mutated) tumours |
Dasatinib | Treatment of the lymphoid blast phase of chronic myeloid leukaemia |
Everolimus | Treatment of progressive unresectable or metastatic well differentiated neuroendocrine tumour of the pancreas |
Lapatinib | In combination with capecitabine chemotherapy for HER-2 receptor positive locally advanced or metastatic breast cancer |
Ofatumumab | Treatment of relapsed or refractory chronic lymphatic leukaemia |
Pazopanib | Treatment of previously treated metastatic non-adipocytic soft tissue sarcomas |
Pegylated liposomal doxorubicin | 1st or 2nd line chemotherapy of angiosarcoma |
Pegylated liposomal doxorubicin | Chemotherapy of primary malignant sarcomas of the heart and great vessels |
Source: National Cancer Drugs Fund List Ver 6.0 | |
Table 2: Confirmation of previously notified drugs and indications delisted on 4 November 2015 | |
Drug | Indication removed |
Albumin bound Paclitaxel | First line treatment of advanced adenocarcinoma of the pancreas in combination with Gemcitabine |
Bendamustine | 2nd or subsequent line treatment of chronic lymphatic leukaemia for patients whom fludarabine combination therapy is not a therapeutic option |
Bendamustine | 2nd and subsequent line of treatment of mantle cell lymphoma in patients who have not received previous Bendamustine |
Bevacizumab | Treatment of patients with triple negative metastatic breast cancer and/or prior Taxane therapy |
Bevacizumab | 2nd or 3rd line treatment of metastatic colorectal cancer in combination with standard chemotherapy in patients who have not previously received Bevacizumab |
Bosutinib | Treatment of chronic phase CML refractory to Nilotinib or Dasatinib |
Bosutinib | Treatment of accelerated phase CML refractory to Nilotinib or Dasatinib |
Bosutinib | Treatment of accelerated phase CML where there is significant intolerance to Dasatinib and Nilotinib. |
Cetuximab | 3rd and subsequent line treatment of metastatic colorectal cancer as a single agent |
Cetuximab | 3rd and subsequent line treatment of metastatic colorectal cancer as a single agent in patients not treated to progression under NICE TA176 |
Dasatinib | Treatment of adults with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL) with resistance or intolerance to prior therapy including Imatinib |
Everolimus | 2nd or 3rd line treatment of metastatic renal cell carcinoma where disease has progressed on or after treatment with VEGF-targeted therapy |
Lenalidomide | 2nd line treatment of multiple myeloma in patients who have contraindications to the use of Bortezomib |
Panitumumab | 3rd and subsequent line treatment of metastatic colorectal cancer as a single agent |
Panitumumab | 3rd and subsequent line treatment of metastatic colorectal cancer as a single agent in patients not treated to progression under NICE TA176 |
Pegylated Liposomal Doxorubicin | 2nd line treatment of Fibromatosis |
Peptide Receptor Radionucleotide Therapy (Lutetium177 Octreotate or Yttrium90 Octreotide/Octreotate) | Treatment of advanced neuro-endocrine tumours i.e. for pNETS after Sunitinib/chemotherapy, for mid-gut carcinoid, after octreotide/somatostatin therapies. |
Pomalidomide | Treatment of relapsed and refractory multiple myeloma in patients who have received at least 2 prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy |
Source: National Cancer Drugs Fund List Ver 6.0 | |
NHS England publishes information on the number of patient applications for particular drugs/indications contained on the national CDF list on a quarterly basis. This information also includes the number of applications approved through the individual CDF request process. The latest information isattached as it is too long to be included in this answer. It is also available at:
www.england.nhs.uk/ourwork/pe/cdf/ and a copy of this is also attached.
The Government is committed to the CDF and is working with NHS England and the National Institute for Health and Care Excellence on the future arrangements for the Fund.
To ask Her Majesty’s Government whether, during the UK's Presidency of the UN Security Council this month, they will refer reports by Radio Dabanga of crimes against humanity in Darfur to the International Criminal Court for investigation.
To ask Her Majesty’s Government whether, during the UK's Presidency of the UN Security Council this month, they will refer reports by Radio Dabanga of crimes against humanity in Darfur to the International Criminal Court for investigation.
The situation in Darfur has already been referred to the International Criminal Court (ICC) by the UN Security Council under UN Security Council Resolution 1593 (2005). As the prosecutor’s investigation is still ongoing, it could encompass any new allegations. However, such a decision would be for the Office of the Prosecutor of the Court to take. The UK remains a strong supporter of the ICC.
My Lords—
My Lords—
My Lords, reverting to the need to eradicate Daesh and its territorial base as part of a comprehensive strategy, does the noble Baroness agree that the YPG is the most effective military force in opposition to Daesh? Will we therefore make supreme efforts to bolster its efforts by supplying armaments...
My Lords, reverting to the need to eradicate Daesh and its territorial base as part of a comprehensive strategy, does the noble Baroness agree that the YPG is the most effective military force in opposition to Daesh? Will we therefore make supreme efforts to bolster its efforts by supplying armaments...
To ask Her Majesty’s Government what progress has been made in implementing the recommendations of the 2014 report of the UK Stem Cell Strategy Oversight Committee on the future of unrelated donor stem cell transplantation in the United Kingdom.
To ask Her Majesty’s Government what progress has been made in implementing the recommendations of the 2014 report of the UK Stem Cell Strategy Oversight Committee on the future of unrelated donor stem cell transplantation in the United Kingdom.
The Government continues to take forward work to deliver the recommendations in the 2014 report. We remain committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor.
Since 2011, the Department has provided its delivery partners, NHS Blood and Transplant and the Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.
This funding has led to a tangible improvement in the availability of stem cells in the UK and the achievements include:
- More UK patients received a stem cell transplant in 2014 than ever before;
- Over 60% of black, Asian and minority ethnic (BAME) patients are now able to find a well matched donor compared to only 40% in 2010;
- A single unified bone marrow donor registry has been created streamlining the provision of stem cells and reducing the time to provide cells from adult donors;
- The proportion of patients receiving cord blood from UK donors has significantly increased; and
- An increase in UK patients receiving a transplant from 802 in 2010/11 to 1,060 in 1013/14. The increased use of UK-sourced stem cells has meant that more donors than ever are available to donate leading to a significant cost saving by reducing the need to import stem cells.
My Lords—
My Lords—
My Lords, will the Government publish a draft of their decision for consultation with the All-Party Group on the Chagos Islands? Will they also give both Houses an opportunity to debate the review before a final decision on resettlement is made?
My Lords, will the Government publish a draft of their decision for consultation with the All-Party Group on the Chagos Islands? Will they also give both Houses an opportunity to debate the review before a final decision on resettlement is made?
My Lords, I draw attention to the dedication of the All-Party Group on this issue over many years. Whether or not there will be an opportunity for this to be debated at some stage will depend on whether noble Lords try to get parliamentary time for it. Once the analysis is made, the Government will make an announcement. I will write to the noble Lord about whether it will be published.
To ask Her Majesty’s Government what discussions they have had with the Saudi-led coalition in Yemen on restoring peace in that country.
To ask Her Majesty’s Government what discussions they have had with the Saudi-led coalition in Yemen on restoring peace in that country.
My Lords, the United Kingdom Government are in regular contact with the Saudi authorities, including through our embassy in Riyadh and our Yemen office based in Jeddah. The Secretary of State for Foreign and Commonwealth Affairs visited Saudi Arabia earlier this week and underlined the importance that the United Kingdom attaches to finding a political solution to the current crisis as soon as possible. He also reinforced the necessity of full compliance with international humanitarian law and of facilitating access for humanitarian and commercial shipping.
My Lords, the Yemen operation has left 5,000 dead, 26,000 injured, 2.3 million internally displaced and 21 million in need of humanitarian assistance. If we agree with the Brookings Institution that al-Qaeda is the principal local winner of this war and with Human Rights Watch that Saudi attacks on IDPs and humanitarian aid are violations of the laws of war, will the Government use our presidency of the Security Council in November to promote a truce and to call for the withdrawal of all foreign forces in Yemen?
My Lords, the Yemen operation has left 5,000 dead, 26,000 injured, 2.3 million internally displaced and 21 million in need of humanitarian assistance. If we agree with the Brookings Institution that al-Qaeda is the principal local winner of this war and with Human Rights Watch that Saudi attacks on IDPs and humanitarian aid are violations of the laws of war, will the Government use our presidency of the Security Council in November to promote a truce and to call for the withdrawal of all foreign forces in Yemen?
My Lords, the noble Lord is right: the situation there at the moment is dreadful. In July it was declared a level 3 emergency, which is reserved for the worst humanitarian crises—shared only, I am afraid, by Syria, Iraq and South Sudan. As the noble Lord said, the intensified conflict has now displaced nearly 2.3 million people. He asked whether there is anything that we can do during our presidency of the Security Council. I will pass on his question to my colleagues in the department, but I can say that UN special envoy Ismail Ould Cheikh Ahmed briefed the Security Council in open session on Friday on his plans for further political negotiation. That is something that we are very pleased about.
I wish to ask the Minister two very brief questions. First, the comment has been made, but not in this debate, about the length of time that people remain on Section 95 support. In 2013, Mark Harper, who was then the Minister in charge of immigration, gave a series of...
I wish to ask the Minister two very brief questions. First, the comment has been made, but not in this debate, about the length of time that people remain on Section 95 support. In 2013, Mark Harper, who was then the Minister in charge of immigration, gave a series of...
But these things were all available to the asylum seeker before these changes were made, so the Government have cut £16 from the family income of the people who were receiving these benefits before.
But these things were all available to the asylum seeker before these changes were made, so the Government have cut £16 from the family income of the people who were receiving these benefits before.
To ask Her Majesty’s Government whether they plan to evaluate the ideas on dealing with corporate international tax avoidance developed by Professor Gabriel Zucman in his book The Hidden Wealth of Nations: The Scourge of Tax Havens.
To ask Her Majesty’s Government whether they plan to evaluate the ideas on dealing with corporate international tax avoidance developed by Professor Gabriel Zucman in his book The Hidden Wealth of Nations: The Scourge of Tax Havens.
The Government considers material from a range of sources as part of the normal policy making process. Professor Gabriel Zucman’s book points out that tax avoidance by large corporations can be stopped, and the UK is addressing this issue through the G20 and OECD Base Erosion and Profit Shifting (BEPS) project. We recognise that the global issue of tax avoidance and aggressive tax planning requires a coordinated approach to come up with effective solutions. This is why the UK is at the forefront of multilateral action through the BEPS project to ensure profits are taxed where economic activities are performed.
The first phase of the BEPS project was delivered in 2014, and the UK was the first adopter of the 2014 recommendations, by legislating for the internationally agreed country-by-country reporting template; and consulting on implementing the OECD agreed rules to deal with hybrid mismatch arrangements.
The final recommendations from the BEPS project were endorsed by the G20 Finance Ministers at their meeting in Lima on 8 October. The project represents major and unprecedented efforts involving over 60 countries to clamp down on aggressive tax planning.
The Government is committed to countering tax avoidance to ensure all tax payers pay their fair share. The UK will give full consideration to the outputs of the BEPS project and we will engage with the OECD’s work on developing a framework for monitoring implementation.